Zur Kurzanzeige

dc.contributor.authorMuro Álvarez, Antonio 
dc.contributor.authorBelhassen García, Moncef 
dc.contributor.authorMuñoz Bellido, Juan Luis 
dc.contributor.authorLorenzo Juanes, Helena
dc.contributor.authorVicente, Belén
dc.contributor.authorPendones, Josué
dc.contributor.authorAdserias, José
dc.contributor.authorSánchez Hernández, Gonzalo
dc.contributor.authorRodríguez Rosa, Miguel 
dc.contributor.authorVicente Villardón, José Luis 
dc.contributor.authorBurguillo Muñoz, Francisco Javier 
dc.contributor.authorLópez Andaluz, Javier
dc.contributor.authorMartín Oterino, José Ángel 
dc.contributor.authorGarcía Criado, Francisco Javier 
dc.contributor.authorBarbero Iglesias, Fausto José 
dc.contributor.authorMorales Martín, Ana Isabel 
dc.contributor.authorGalindo Villardón, Purificación 
dc.contributor.authorGonzález Sarmiento, Rogelio 
dc.date.accessioned2025-01-22T11:56:31Z
dc.date.available2025-01-22T11:56:31Z
dc.date.issued2021-07-21
dc.identifier.citationMuro, A., Belhassen-García, M., Muñoz Bellido, J. L., Lorenzo Juanes, H., Vicente, B., Pendones, J., Adserias, J., Sánchez Hernández, G., Rodríguez Rosa, M., Vicente Villardón, J. L., Burguillo, J., López Andaluz, J., Martín Oterino, J. A., García Criado, F. J., Barbero, F., Morales, A. I., Galindo Villardón, P., González Sarmiento, R., & on behalf of the DIANCUSAL Team. (2021). Seroprevalence of SARS-CoV-2 Antibodies and Factors Associated with Seropositivity at the University of Salamanca: The DIANCUSAL Study. Journal of Clinical Medicine, 10(15), 3214. https://doi.org/10.3390/jcm10153214es_ES
dc.identifier.issn2077-0383
dc.identifier.urihttp://hdl.handle.net/10366/162278
dc.description.abstract[EN]Background: Systematic screening for antibodies against SARS-CoV-2 is a crucial tool for surveillance of the COVID-19 pandemic. The University of Salamanca (USAL) in Spain designed a project called “DIANCUSAL” (Diagnosis of New Coronavirus, COVID-19, in University of Salamanca) to measure antibodies against SARS-CoV-2 among its ~34,000 students and academic staff, as the influence of the university community in the spread of the SARS-CoV-2 pandemic in the city of Salamanca and neighboring towns hosting USAL campuses could be substantial. Objective: The aim of this study was to estimate the prevalence of SARS-CoV-2 antibodies among USAL students, professors and staff and to evaluate the demographic, academic, clinical and lifestyle and behavioral factors related to seropositivity. Methodology: The DIANCUSAL study is an ongoing university population-based cross-sectional study, with the work described herein conducted from July–October 2020. All USAL students, professors and staff were invited to complete an anonymized questionnaire. Seroprevalence of anti-SARS-CoV-2 antibodies was detected and quantified by using chemiluminescent assays for IgG and IgM. Principal findings: A total of 8197 (24.71%) participants were included. The mean age was 31.4 (14.5 SD) years, and 66.0% of the participants were female. The seroprevalence was 8.25% overall and was highest for students from the education campus (12.5%) and professors from the biomedical campus (12.6%), with significant differences among faculties (p = 0.006). Based on the questionnaire, loss of smell and fever were the symptoms most strongly associated with seropositivity, and 22.6% of seropositive participants were asymptomatic. Social distancing was the most effective hygiene measure (p = 0.0007). There were significant differences in seroprevalence between participants with and without household exposure to SARS-CoV-2 (p = 0.0000), but not between students who lived in private homes and those who lived in dormitories. IgG antibodies decreased over time in the participants with confirmed self-reported COVID-19 diagnoses. Conclusions: The analysis revealed an overall 8.25% seroprevalence at the end of October 2020, with a higher seroprevalence in students than in staff. Thus, there is no need for tailored measures for the USAL community as the official average seroprevalence in the area was similar (7.8% at 22 June and 12.4 at 15 November of 2020). Instead, USAL members should comply with public health measures.es_ES
dc.description.sponsorshipThe University of Salamanca (USAL).es_ES
dc.language.isoenges_ES
dc.publisherMDPIes_ES
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subjectSARS-CoV-2es_ES
dc.subjectCOVID-19es_ES
dc.subjectAntibodieses_ES
dc.subjectSeroprevalencees_ES
dc.subjectScreeninges_ES
dc.subjectUniversityes_ES
dc.subjectSalamancaes_ES
dc.subjectSpaines_ES
dc.titleSeroprevalence of SARS-CoV-2 Antibodies and Factors Associated with Seropositivity at the University of Salamanca: The DIANCUSAL Studyes_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.relation.publishversionhttps://doi.org/10.3390/jcm10153214es_ES
dc.identifier.doi10.3390/jcm10153214
dc.rights.accessRightsinfo:eu-repo/semantics/openAccesses_ES
dc.journal.titleJournal of Clinical Medicinees_ES
dc.volume.number10es_ES
dc.issue.number15es_ES
dc.page.initial3214es_ES
dc.type.hasVersioninfo:eu-repo/semantics/publishedVersiones_ES


Dateien zu dieser Ressource

Thumbnail

Das Dokument erscheint in:

Zur Kurzanzeige

Attribution-NonCommercial-NoDerivatives 4.0 Internacional
Solange nicht anders angezeigt, wird die Lizenz wie folgt beschrieben: Attribution-NonCommercial-NoDerivatives 4.0 Internacional